Artemisinin resistance – modelling the potential human and economic costs

Mind the gaps - the epidemiology of poor-quality anti-malarials in the malarious world - analysis of the WorldWide Antimalarial Resistance Network database

(2014) Patricia Tabernero et al.   MALARIA JOURNAL

Dihydroartemisinin-Piperaquine vs. Artemether-Lumefantrine for First-Line Treatment of Uncomplicated Malaria in African Children: A Cost-Effectiveness Analysis

(2014) Johannes Pfeil et al.   PLoS One

Malaria Transmission After Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine: A Randomized Trial

(2013) Patrick Sawa et al.   JOURNAL OF INFECTIOUS DISEASES

Malaria Burden and Artemisinin Resistance in the Mobile and Migrant Population on the Thai–Myanmar Border, 1999–2011: An Observational Study

(2013) Verena I. Carrara et al.   PLOS MEDICINE

Effect of High-Dose or Split-Dose Artesunate on Parasite Clearance in Artemisinin-Resistant Falciparum Malaria

(2012) Debashish Das et al.   CLINICAL INFECTIOUS DISEASES

Global malaria mortality between 1980 and 2010: a systematic analysis

(2012) Christopher JL Murray et al.   LANCET

Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data

(2012) Sarah Tougher et al.   LANCET

Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study

(2012) Aung Pyae Phyo et al.   LANCET

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa

(2011) Yoel Lubell et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries

(2011) Kathryn A O'Connell et al.   MALARIA JOURNAL

Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries

(2011) Megan Littrell et al.   MALARIA JOURNAL

Case management of malaria fever in Cambodia: results from national anti-malarial outlet and household surveys

(2011) Megan Littrell et al.   MALARIA JOURNAL

Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey

(2011) Yoel Lubell et al.   PLoS One

Exploring the Contribution of Candidate Genes to Artemisinin Resistance in Plasmodium falciparum

(2010) M. Imwong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Changes in the burden of malaria in sub-Saharan Africa

(2010) Wendy Prudhomme O'Meara et al.   LANCET INFECTIOUS DISEASES

The economic costs of malaria in four Kenyan districts: do household costs differ by disease endemicity?

(2010) Jane Chuma et al.   MALARIA JOURNAL

Intrahost modeling of artemisinin resistance in Plasmodium falciparum

(2010) S. Saralamba et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The value of productivity: human-capital versus friction-cost method

(2009) W B van den Hout   ANNALS OF THE RHEUMATIC DISEASES

ORIGINAL ARTICLE: Probability of emergence of antimalarial resistance in different stages of the parasite life cycle

(2009) Wirichada Pongtavornpinyo et al.   Evolutionary Applications

The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia

(2009) Richard J Maude et al.   MALARIA JOURNAL

Artemisinin Resistance inPlasmodium falciparumMalaria

(2009) Arjen M. Dondorp et al.   NEW ENGLAND JOURNAL OF MEDICINE